Immunocytochemical detection of p53 in cultures of exfoliated cells from urine of patients with urothelial cancers

Japanese Journal of Cancer Research

Volumn 87, Issue 7, 1996, Pages 718-723

  Okuno, Hiroshi ^a   Kakehi, Yoshiyuki ^a   Ogawa, Osamu ^a   Yamada, Hitoshi ^a   Özdemir, Enver ^a   Okada, Yusaku ^a   Yoshida, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Exfoliated cells in urine; Immunocytochemistry; p53; Short term culture; Urothelial cancer

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CELL CULTURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; URINE; URINE CYTOLOGY; UROGENITAL TRACT CANCER;

EID: 0029785287     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00283.x     Document Type: Article

References (21)

1. Habuchi, T., Ogawa, O., Kakehi, Y., Ogura, K., Koshiba, M., Sugiyama, T. and Yoshida, O. Allelic loss of chromosome 17p in urothelial cancer: strong association with invasive phenotype. J. Urol., 148, 1595-1599 (1992).
2. Habuchi, T., Takahashi, R., Yamada, H., Ogawa, O., Kakehi, Y., Ogura, K., Hamazaki, S., Toguchida, J., Ishizaki, K., Fujita, J., Sugiyama, T. and Yoshida, O. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res., 53, 3795-3799 (1993).
3. Sidransky, D., Eschenbach, A. V., Tsai, Y. C., Jones, P., Summerhayes, L., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P. and Vogelstein, B. Identification of p53 gene mutation in bladder cancers and urine samples. Science, 252, 706-709 (1991).
4. Esrig, D., Spruck III, C. H., Nichols, P. W., Chaiwun, B., Steven, K, Groshen, S., Chen, S., Skinner, D. G., Jones, P. H. and Cote, R. J. p53 Nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am. J. Pathol., 143, 1389-1397 (1993).
5. Uchida, T., Wada, C., Ishida, H., Wang, C., Egawa, S., Yokomeya, E., Kameya, T. and Koshiba, K. p53 Mutations and prognosis in bladder tumors. J. Urol., 153, 1097-1104 (1995).
6. Herz, F., Deitch, D., Adler, S. A. and Brijlall, D. Short-term culture of exfoliated cells from the urine of patients with bladder tumors. Urol. Res., 21, 23-26 (1993).
7. Mostofi, F. K., Sobin, L. H. and Torloni, H. "International Histological Classification of Tumours. 10. Histological Typing of Urinary Bladder Tumours" (1973). World Health Organization, Geneva.
8. Isaacs, W. B., Carter, B. S. and Ewing, C. M. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res., 51, 4716-4720 (1991).
9. Esrig, D., Elmajian, D., Groshen, S., Freeman, J. A., Stein, J. P., Chen, S., Nichols, P. W., Skinner, D. G., Jones., P. A. and Cote, R. J. Accumulation of nuclear p53 and tumor progression in bladder cancer. N. Engl J. Med., 331, 1259-1264 (1994).
10. Chin, N. W., Zhang, R., Nostro, D. C. and Lanks, K. W. A novel monoclonal antibody to cytokeratin 18 with reactivity toward lung squamous cell carcinomas and adenocarcinomas of various sites. Am. J. Pathol., 140, 1061-1069 (1992).
11. Shokri-Tabibzadeh, S., Herz, F. and Koss, L.G. Fine structure of cultured epithelial cells derived from voided urine of normal adults. Virchows Arch., 39, 41-48 (1982).
12. Cripps, K. J., Purdie, C. A., Carder, P. J., White, S., Komine, K., Bird, C. C. and Wyllie, A. H. A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma. Oncogene, 9, 2739-2743 (1994).
13. Spruck III, C. H., Ohneseit, P. F., Gonzales-Zulueta, M., Esrig, D., Miyao, N., Tsai, Y. C., Lerner, S. P., Schmütte, C., Yang, A. S., Cote, R., Dubeau, L., Nichols, P. W., Hermann, G. G., Steven, K., Horn, T., Skinner, D. G. and Jones, P. A. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54, 784-788 (1994).
14. Hall, P. A., McKee, P.H., Menage, H. D., Dover, R. and Lane, D. P. High level of p53 protein in UV-irradiated normal human skin. Oncogene, 8, 203-207 (1993).
15. Takeda, S., Ichii, S. and Nakamura, Y. Detection of k-ras mutation in sputum by mutant-allele-specific amplification (MASA). Hum. Mutat., 2, 112-117 (1993).
16. Sidransky, D., Eschenbach, A. V., Tsai, Y. C., Jones, P., Summerhayes, L., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P. and Vogelstein, B. Identification of p53 gene mutation in bladder cancers and urine samples. Science, 252, 706-709 (1991).
17. Fitzgerald, J. M., Ramchurren, N., Riege, K., Levesque, P., Silverman, M., Libertino, J. A. and Summerhayes, I. C. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors. J. Natl. Cancer Inst., 87, 129-133 (1995).
18. Mao, L., Schoenberg, M. P., Scicchitano, M., Erozan, Y. S., Merlo, A., Schwab, D. and Sidransky, D. Molecular detection of primary bladder cancer by microsatellite analysis. Science, 271, 659-662 (1996).
19. Lönn, U., Lönn, S., Nylen, U., Friberg, S. and Stenkvist, B. Gene amplification detected in carcinoma cells from human urinary bladder washings by the polymerase chain reaction method. Cancer, 71, 3605-3610 (1993).
20. Hayashi, N., Arakawa, H., Nagase, H., Yanagisawa, A., Kato, Y., Ohta, H., Takano, S., Ogawa, M. and Nakamura, Y. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method. Cancer Res., 54, 3853-3856 (1994).
21. Hayashi, N., Yanagisawa, A., Kato, Y., Nakamura, S., Imaoka, S., Watanabe, H., Ogawa, M. and Nakamura, Y. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet, 345, 1257-1259 (1995).